Online Webinar 2019 - The Importance of Packaging and Labeling in Pharmaceutical Production – Best Practices
Topics/Call fo Papers
Overview
Occupying a critical position in the success or failure of any pharmaceutical product launch, Packaging and Labeling form a bridge between the conception of a product and its realization and distribution. Their activities are also crucial for compliance with regulatory agency requirements.
Still, their importance is often underestimated, especially in the planning phases, which leads to unnecessary increases in cycle time, costly errors, delays in product availability, or product recalls due to noncompliance. Understanding the packaging and labeling process in the larger product development process will provide you an advantage in achieving success.
Learning Objectives:
After completing this course, you’ll be able to:
Articulate Packaging and Labeling’s role in product development
Ensure adherence to regulatory agency requirements
Anticipate potential obstacles in marketing, medical affairs, regulatory, legal or quality assurance
Work effectively with contract manufacturers or packagers
Manage labeling in foreign languages
Avoid unnecessary production costs, back orders and recalls, especially during product launches
Session Highlights
Regulatory Agency Requirements
SOPs and Change Control considerations related to packaging
Packaging and Labeling Interactions
Creation of the Package
Codes
Packaging Errors
Labeling Errors
Supply Chain Issues
Special Considerations (e.g. Product Launches, Clinical vs. Commercial packaging)
Who Should Attend
Operations Departments
Regulatory Affairs Departments
Labeling and Packaging Departments
Quality Assurance Departments
Production Control Departments
Packaging Technology Departments
Labeling Coordination Departments
Package Engineering Departments
Packaging Operations Departments
Project Management
Sales and Marketing Departments
Speaker Profile
Michael Esposito has over 30 years experience in the pharmaceutical industry and 17 years experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer and Johnson & Johnson's McNeil Consumer Healthcare Division in a variety of areas including Packaging, project administration, Quality Assurance, Government Contracts, translations, systems training, and international operations. He collaborated in the development and implementation of the training portion of the Consent Decree workplan for McNeil and revised their introductory GMP course.
Occupying a critical position in the success or failure of any pharmaceutical product launch, Packaging and Labeling form a bridge between the conception of a product and its realization and distribution. Their activities are also crucial for compliance with regulatory agency requirements.
Still, their importance is often underestimated, especially in the planning phases, which leads to unnecessary increases in cycle time, costly errors, delays in product availability, or product recalls due to noncompliance. Understanding the packaging and labeling process in the larger product development process will provide you an advantage in achieving success.
Learning Objectives:
After completing this course, you’ll be able to:
Articulate Packaging and Labeling’s role in product development
Ensure adherence to regulatory agency requirements
Anticipate potential obstacles in marketing, medical affairs, regulatory, legal or quality assurance
Work effectively with contract manufacturers or packagers
Manage labeling in foreign languages
Avoid unnecessary production costs, back orders and recalls, especially during product launches
Session Highlights
Regulatory Agency Requirements
SOPs and Change Control considerations related to packaging
Packaging and Labeling Interactions
Creation of the Package
Codes
Packaging Errors
Labeling Errors
Supply Chain Issues
Special Considerations (e.g. Product Launches, Clinical vs. Commercial packaging)
Who Should Attend
Operations Departments
Regulatory Affairs Departments
Labeling and Packaging Departments
Quality Assurance Departments
Production Control Departments
Packaging Technology Departments
Labeling Coordination Departments
Package Engineering Departments
Packaging Operations Departments
Project Management
Sales and Marketing Departments
Speaker Profile
Michael Esposito has over 30 years experience in the pharmaceutical industry and 17 years experience in GMP training and document management. He has worked for Wyeth Pharmaceuticals, Pfizer and Johnson & Johnson's McNeil Consumer Healthcare Division in a variety of areas including Packaging, project administration, Quality Assurance, Government Contracts, translations, systems training, and international operations. He collaborated in the development and implementation of the training portion of the Consent Decree workplan for McNeil and revised their introductory GMP course.
Other CFPs
- CMO Supplier Quality Agreements - What you need to know to comply with new FDA & EU GMP Guidelines for contract drug manufacture
- Strategies to Prevent Manufacture and Distribution of Substandard Medications
- 6-Hour Virtual Seminar 21 CFR Part 11 (Electronic Records/Electronic Signatures) Compliance for Computer Systems Regulated by FDA
- How to Establish an Effective IT Governance, Risk and Compliance (GRC) Framework - Organization and Responsibilities
- Patient Access to Health Information, Texting, and E-mail — HIPAA Requirements for Easy, Low-cost Access by Jim Sheldon-Dean
Last modified: 2019-04-04 19:49:03